Breakthroughs in CAR T-Cell Therapies Show Promise for Solid Tumor Cancers

Briefs - cytomed

Menu

Home
About
Platform
- CAR-γδ T Cell
- iPSC-γδ NKT Cell
Pipeline
Investor
- Investor Relations
- Financial Reports
Banking Services
Contact Us
Shareholder Benefits
Make An Appointment

Email:

enquiry@cytomed.sg

Phone:

+607-3824911
+65-62507738

Quick Links

Home
About Us
Publications
Contact Us

Let's Get Connected!

CytoMed Therapeutics Limited (201808327H)

Registered Office:

1 Commonwealth Lane #08-22, Singapore 149544

CytoMed Therapeutics (Malaysia) Sdn Bhd (1074609-M)

Head Office & GMP Facility:

No.12 Jalan Permas 9/16, Bandar Baru Permas Jaya, 81750 Johor Bahru, Johor Darul Ta'zim, Malaysia

© 2025 CytoMed Therapeutics Limited

Whistleblower Policy PDP Notice (EN) PDP Notice (BM)

Designed & Developed by Klizo Solutions Pvt. Ltd.